Turkey · Delayed Price · Currency is TRY IST:SURGY Statistics
Total Valuation
IST:SURGY has a market cap or net worth of TRY 4.90 billion. The enterprise value is 4.86 billion.
| Market Cap | 4.90B |
| Enterprise Value | 4.86B |
Important Dates
The next estimated earnings date is Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IST:SURGY has 167.50 million shares outstanding. The number of shares has decreased by -4.05% in one year.
| Current Share Class | 165.43M |
| Shares Outstanding | 167.50M |
| Shares Change (YoY) | -4.05% |
| Shares Change (QoQ) | +16.75% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.05% |
| Float | n/a |
Valuation Ratios
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 78.38 |
| PB Ratio | 0.46 |
| P/TBV Ratio | 0.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 77.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.62
| Current Ratio | 2.62 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -233.21 |
Financial Efficiency
Return on equity (ROE) is -10.02% and return on invested capital (ROIC) is -7.32%.
| Return on Equity (ROE) | -10.02% |
| Return on Assets (ROA) | -3.47% |
| Return on Invested Capital (ROIC) | -7.32% |
| Return on Capital Employed (ROCE) | -5.33% |
| Weighted Average Cost of Capital (WACC) | 9.25% |
| Revenue Per Employee | 961,366 |
| Profits Per Employee | -14.92M |
| Employee Count | 65 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IST:SURGY has paid 240.24 million in taxes.
| Income Tax | 240.24M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.33% in the last 52 weeks. The beta is 0.91, so IST:SURGY's price volatility has been similar to the market average.
| Beta (5Y) | 0.91 |
| 52-Week Price Change | -46.33% |
| 50-Day Moving Average | 55.86 |
| 200-Day Moving Average | 57.92 |
| Relative Strength Index (RSI) | 12.83 |
| Average Volume (20 Days) | 7,867,491 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IST:SURGY had revenue of TRY 62.49 million and -969.97 million in losses. Loss per share was -6.04.
| Revenue | 62.49M |
| Gross Profit | 29.39M |
| Operating Income | -755.77M |
| Pretax Income | -729.73M |
| Net Income | -969.97M |
| EBITDA | -753.50M |
| EBIT | -755.77M |
| Loss Per Share | -6.04 |
Balance Sheet
The company has 32.76 million in cash and no debt, with a net cash position of 32.76 million or 0.20 per share.
| Cash & Cash Equivalents | 32.76M |
| Total Debt | n/a |
| Net Cash | 32.76M |
| Net Cash Per Share | 0.20 |
| Equity (Book Value) | 10.68B |
| Book Value Per Share | 54.61 |
| Working Capital | 1.83B |
Cash Flow
| Operating Cash Flow | -199.62M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 47.03% |
| Operating Margin | -1,209.46% |
| Pretax Margin | -1,167.79% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IST:SURGY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.05% |
| Shareholder Yield | 4.05% |
| Earnings Yield | -19.80% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |